RAPP - Company ID 0002012593
As of 2026-11-06, Rapport Therapeutics, Inc. (RAPP) has a market capitalization of $1.17 B, making it the #2462 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $1.17 B |
| 2026-11-05 | $1.13 B |
| 2026-11-04 | $1.24 B |
| 2026-11-03 | $1.21 B |
| 2026-11-02 | $1.20 B |
| 2026-11-01 | $1.20 B |
| 2026-10-31 | $1.20 B |
| 2026-10-30 | $1.21 B |
| 2026-10-29 | $1.16 B |
| 2026-10-28 | $1.10 B |
| 2026-10-27 | $1.34 B |
| 2026-10-26 | $1.21 B |
As of 2026-11-06, Rapport Therapeutics, Inc. (RAPP) has a market capitalization of $1.17 B, making it the #2462 most valuable US-listed company.
Rapport Therapeutics, Inc. is the #2462 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $1.24 B |
| 2026-10-24 | $1.24 B |
| 2026-10-23 | $1.24 B |
| 2026-10-22 | $1.25 B |
| 2026-10-21 | $1.20 B |
| 2026-10-20 | $1.40 B |
| 2026-10-19 | $1.37 B |
| 2026-10-18 | $1.32 B |
| 2026-10-17 | $1.32 B |
| 2026-10-16 | $1.32 B |
| 2026-10-15 | $1.42 B |
| 2026-10-14 | $1.35 B |
| 2026-10-13 | $1.39 B |
| 2026-10-12 | $1.44 B |
| 2026-10-11 | $1.47 B |
| 2026-10-10 | $1.47 B |
| 2026-10-09 | $1.47 B |
| 2026-10-08 | $1.43 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.